Cancer Letters

Show Articles
Journal Properties
  • Country
    Ireland
  • Language
    English
  • Number of Articles
    17,580
  • Abbreviation
    Cancer Lett
  • ISSN
    0304-3835
  • Main Publisher
    Elsevier
  • Publisher
    Elsevier BV
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Journal Properties
  • Medicine
    Internal medicine
    Neoplasms
    Tumors
    Oncology
    Including cancer and carcinogens
    Medicine
    Medicine (General)
  • website
Description
Cancer Letters is a prestigious international journal dedicated to publishing high-impact research articles and reviews covering all aspects of cancer research. As a leading platform for disseminating cutting-edge discoveries, the journal serves as an essential resource for scientists, clinicians, and healthcare professionals worldwide. The scope encompasses both basic and translational research, addressing the complexities of cancer biology, prevention, diagnosis, and treatment. Key areas of interest include cancer genetics, molecular biology, immunology, pharmacology, and clinical oncology. The journal also features studies on novel therapeutic strategies, biomarkers, and innovative technologies for cancer detection and management. Indexed in prominent databases such as PubMed, Scopus, and Web of Science, Cancer Letters ensures broad visibility and accessibility for published research. Its target audience includes cancer researchers, oncologists, and healthcare professionals seeking the latest advances in cancer science. Authors are encouraged to submit high-quality manuscripts that contribute to the understanding and treatment of cancer. By maintaining rigorous editorial standards and promoting interdisciplinary collaboration, Cancer Letters continues to play a critical role in advancing the fight against cancer and improving patient outcomes.